Kirk A Keegan

Title(s)Emeritus, Obstetrics and Gynecology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5968
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study. Eur Urol Open Sci. 2024 Apr; 62:8-15. P van Valenberg FJ, van der Heijden AG, Cutie CJ, Bhanvadia S, Keegan KA, Hampras S, Sweiti H, Maffeo JC, Jin S, Chau A, Reynolds DL, Iarossi C, Kelley A, Li X, Stromberg KA, Michiel Sedelaar JP, Steenbruggen JJO, Somford DM, Alfred Witjes J. PMID: 38585206; PMCID: PMC10998271.
      View in: PubMed   Mentions:
    2. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study. J Urol. 2023 05; 209(5):890-900. Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. PMID: 37026631.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Reply by Authors. J Urol. 2023 05; 209(5):900. Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. PMID: 37026638.
      View in: PubMed   Mentions:    Fields:    
    4. The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial. Urol Oncol. 2022 07; 40(7):344.e1-344.e9. Daneshmand S, Brummelhuis ISG, Pohar KS, Steinberg GD, Aron M, Cutie CJ, Keegan KA, Maffeo JC, Reynolds DL, Raybold B, Chau A, Witjes JA. PMID: 35431132.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer. Urol Oncol. 2022 06; 40(6):273.e1-273.e9. Golla V, Shan Y, Farran EJ, Stewart CA, Vu K, Yu A, Khaki AR, Parikh DA, Swanson TA, Keegan KA, Kamat AM, Tyler DS, Freedland SJ, Williams SB. PMID: 35168881.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 03; 81(3):223-228. Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. PMID: 34933753; PMCID: PMC8891058.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma. J Cancer Res Ther. 2021 Apr-Jun; 17(2):420-425. Balci M, Glaser ZA, Chang SS, Herrell SD, Barocas DA, Keegan KA, Moses KA, Resnick MJ, Smith JA, Penson DF, Scarpato K, Clark PE. PMID: 34121687.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117. Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. PMID: 33253641; PMCID: PMC7988888.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCellsCTClinical Trials
    9. Predictors of Compliance with Muscle Invasive Bladder Cancer Quality Measures and its Effect on Survival Outcomes. Urol Pract. 2021 Jan; 8(1):65-70. Joyce DD, Lee DJ, Demirdag C, Keegan KA, Barocas DA. PMID: 37145422.
      View in: PubMed   Mentions:
    10. Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape. Onco Targets Ther. 2020; 13:3571-3581. Hall ME, Huelster HL, Luckenbaugh AN, Laviana AA, Keegan KA, Klaassen Z, Moses KA, Wallis CJD. PMID: 32431511; PMCID: PMC7201221.
      View in: PubMed   Mentions: 10  
    11. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020 06 10; 38(17):1963-1996. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. PMID: 31940221.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    12. Editorial Comment. J Urol. 2019 04; 201(4):749. Keegan KA. PMID: 30947453.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Oncologic outcomes in patients with nonurothelial bladder cancer. Indian J Urol. 2018 Jan-Mar; 34(1):39-44. Patel SG, Weiner AB, Keegan K, Morgan T. PMID: 29343911; PMCID: PMC5769248.
      View in: PubMed   Mentions: 7  
    14. Creation and Execution of a Novel Anesthesia Perioperative Care Service at a Veterans Affairs Hospital. Anesth Analg. 2017 11; 125(5):1526-1531. Alvis BD, King AB, Pandharipande PP, Weavind LM, Avila K, Leisy PJ, Ajmal M, McHugh M, Keegan KA, Baker DA, Walia A, Hughes CG. PMID: 28632542; PMCID: PMC10182402.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol. 2018 01; 36(1):10.e7-10.e14. Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA. PMID: 29055518; PMCID: PMC10184495.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int. 2016; 97(2):134-41. Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM. PMID: 27462702; PMCID: PMC10176496.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer. Bladder (San Franc). 2016; 3(2). Tyson MD, Chang SS, Keegan KA. PMID: 28261632; PMCID: PMC5336315.
      View in: PubMed   Mentions: 1  
    18. A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine. J Endourol. 2015 Sep; 29(9):1019-24. Knight RB, Walker PW, Keegan KA, Overholser SM, Baumgartner TS, Ebertowski JS, Aden JK, White MA. PMID: 25897552.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2016 Jan; 34(1):97-103. Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. PMID: 25981402; PMCID: PMC10176500.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    20. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol. 2015 Aug; 26(8):1754-9. Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA. PMID: 25969370.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    21. Increasing use of observation among men at low risk for prostate cancer mortality. J Urol. 2015 Mar; 193(3):801-6. Ritch CR, Graves AJ, Keegan KA, Ni S, Bassett JC, Chang SS, Resnick MJ, Penson DF, Barocas DA. PMID: 25196658; PMCID: PMC4363002.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    22. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int. 2014 Jun; 113(6):894-9. Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, Cookson MS, Penson DF, Davis R, Clark PE, Smith JA, Chang SS. PMID: 24053444; PMCID: PMC3874077.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    23. Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States. Curr Urol Rep. 2014 Apr; 15(4):394. Keegan KA, Zaid HB, Patel SG, Chang SS. PMID: 24566815; PMCID: PMC4469382.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    24. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. 2015 Jan; 67(1):165-170. Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS. PMID: 24472710; PMCID: PMC4469385.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    25. Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device. Urol Oncol. 2014 Jan; 32(1):45.e11-5. Thompson IM, Kappa SF, Morgan TM, Barocas DA, Bischoff CJ, Keegan KA, Stratton KL, Clark PE, Resnick MJ, Smith JA, Cookson MS, Chang SS. PMID: 24054870; PMCID: PMC4469381.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. A 57-year-old man with a history of prostatectomy and pelvic irradiation presents with recurrent urinary tract infections, hematuria, and pelvic pain. Urology. 2013 Feb; 81(2):221-5. Moore DC, Keegan KA, Resnick MJ, Eisenberg R, Holt GE, Cookson MS. PMID: 23374762; PMCID: PMC3698486.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    27. Editorial comment. J Urol. 2013 Jan; 189(1):85. Keegan KA. PMID: 23164380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Volume outcomes of cystectomy--is it the surgeon or the setting? J Urol. 2012 Dec; 188(6):2139-44. Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF. PMID: 23083864.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    29. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol. 2013 Feb; 189(2):507-13. Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, Penson DF, Davis R, Clark PE, Chang SS, Cookson MS, Herrell SD, Smith JA. PMID: 23000849; PMCID: PMC3698478.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    30. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan; 63(1):45-57. Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladd. PMID: 22917985.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    31. The Patient Protection and Affordable Care Act: the impact on urologic cancer care. Urol Oncol. 2013 Oct; 31(7):980-4. Keegan KA, Penson DF. PMID: 22819697; PMCID: PMC3773249.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    32. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012 Aug; 188(2):391-7. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. PMID: 22698625; PMCID: PMC3714400.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    33. Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Curr Opin Oncol. 2012 May; 24(3):278-83. Keegan KA, Resnick MJ, Clark PE. PMID: 22273550; PMCID: PMC3698482.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Editorial comment. J Urol. 2012 Jun; 187(6):2092-3. Keegan KA. PMID: 22498213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Active surveillance for prostate cancer compared with immediate treatment: an economic analysis. Cancer. 2012 Jul 15; 118(14):3512-8. Keegan KA, Dall'Era MA, Durbin-Johnson B, Evans CP. PMID: 22180322; PMCID: PMC3698480.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    36. Inferior vena cava filter strut perforation discovered during right robotic-assisted laparoscopic partial nephrectomy. Urology. 2012 Apr; 79(4):e49-50. Kappa SF, Morgan TM, Keegan KA, Cookson MS. PMID: 22014963.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011 Sep; 186(3):829-34. Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA, Cookson MS. PMID: 21788035; PMCID: PMC6472701.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    38. Editorial comment. J Urol. 2011 Aug; 186(2):492-3. Keegan K. PMID: 21679998.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Complications of pelvic lymph node dissection for prostate cancer. Curr Urol Rep. 2011 Jun; 12(3):203-8. Keegan KA, Cookson MS. PMID: 21394597.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    40. Bladder cancer. Curr Opin Oncol. 2011 May; 23(3):275-82. Morgan TM, Keegan KA, Clark PE. PMID: 21311329.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    41. Contemporary open ureteral reimplantation without morphine: assessment of pain and outcomes. J Urol. 2009 Sep; 182(3):1147-51. Chamie K, Chi A, Hu B, Keegan KA, Kurzrock EA. PMID: 19625056.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Female urethral stricture disease. Curr Urol Rep. 2008 Sep; 9(5):419-23. Keegan KA, Nanigian DK, Stone AR. PMID: 18702927.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    43. Ship in a bottle: rapid extraction of large intravesical foreign bodies. Urology. 2006 Mar; 67(3):612-3. DeLair SM, Bernal RM, Keegan KA, Ellison LM. PMID: 16504261.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Interdelivery interval and the success of vaginal birth after cesarean delivery. Obstet Gynecol. 2002 Jan; 99(1):41-4. Huang WH, Nakashima DK, Rumney PJ, Keegan KA, Chan K. PMID: 11777508.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    45. The "dangerous multipara": fact or fiction? Am J Obstet Gynecol. 1995 Feb; 172(2 Pt 1):683-6. Toohey JS, Keegan KA, Morgan MA, Francis J, Task S, deVeciana M. PMID: 7856706.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    46. Effects of rotation discipline on medical student grades in obstetrics and gynecology throughout the academic year. Am J Obstet Gynecol. 1993 Nov; 169(5):1215-7. Manetta A, Manetta E, Emma D, Keegan KA, Williams JH. PMID: 8238186.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Fetal choroid plexus cysts: an independent risk factor for chromosomal anomalies. J Clin Ultrasound. 1993 Feb; 21(2):103-8. Porto M, Murata Y, Warneke LA, Keegan KA. PMID: 8381128.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    48. Hyperstimulation contraction stress tests: an evaluation of outcome by test pattern. Am J Perinatol. 1991 Sep; 8(5):304-7. Helm DA, Keegan KA, Porto M. PMID: 1760063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Management of isoimmunized pregnancy by use of intravascular techniques. Am J Obstet Gynecol. 1990 Jan; 162(1):291-3. Porto M, Murata Y, Keegan KA. PMID: 2105649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Quantitation of uterine activity preceding preterm, term, and postterm labor. Am J Obstet Gynecol. 1988 Jun; 158(6 Pt 1):1254-9. Nageotte MP, Dorchester W, Porto M, Keegan KA, Freeman RK. PMID: 3273360.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. The nonstress test. Clin Obstet Gynecol. 1987 Dec; 30(4):921-35. Keegan KA. PMID: 3319323.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Effects of norepinephrine on lung fluid flow rate in the chronically catheterized fetal lamb. Am J Obstet Gynecol. 1987 Oct; 157(4 Pt 1):986-90. Higuchi M, Murata Y, Miyake Y, Hesser J, Tyner J, Keegan KA, Porto M. PMID: 3674175.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    53. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol. 1987 Aug; 157(2):388-93. Garite TJ, Keegan KA, Freeman RK, Nageotte MP. PMID: 3303937.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    54. A prospective evaluation of nipple stimulation techniques for contraction stress testing. Am J Obstet Gynecol. 1987 Jul; 157(1):121-5. Keegan KA, Helm DA, Porto M, Murata Y, Schmidt PL. PMID: 3605244.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Effect of arginine vasopressin on arterial oxygen partial pressure in the chronically catheterized fetal lamb. Nihon Sanka Fujinka Gakkai Zasshi. 1987 Jun; 39(6):995-7. Bessho T, Murata Y, Ibara S, Tyner JG, Keegan KA, Porto M, Schmidt PL. PMID: 3611875.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    56. Abnormal fetal heart rate pattern associated with severe intrapartum maternal ethanol intoxication. A case report. J Reprod Med. 1987 Feb; 32(2):144-6. Silva PD, Miller KD, Madden J, Keegan KA. PMID: 3560078.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    57. Activation of intrinsic coagulation pathway in pre-eclampsia. Am J Med. 1986 Jan; 80(1):103-7. Vaziri ND, Toohey J, Powers D, Keegan K, Gupta A, Alikhani S, Mashood M, Barbari A. PMID: 3079949.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Obstetric characteristics and fetal heart rate patterns of infants who convulse during the newborn period. Am J Obstet Gynecol. 1985 Dec 01; 153(7):732-7. Keegan KA, Waffarn F, Quilligan EJ. PMID: 4073136.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Use of fetal scalp hematocrit in the diagnosis of severe hemorrhage from vasa previa. Am J Obstet Gynecol. 1985 Oct 01; 153(3):307-8. Silva PD, Stoskopf CG, Keegan KA, Murata Y. PMID: 4050896.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Human breast milk concentration of moxalactam. Am J Obstet Gynecol. 1984 Feb 01; 148(3):348-9. Miller RD, Keegan KA, Thrupp LD, Brann J. PMID: 6695987.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Atrial hemangioma and hydrops fetalis. Am J Obstet Gynecol. 1981 Sep 01; 141(1):107-9. Platt LD, Geierman CA, Turkel SB, Young G, Keegan KA. PMID: 7270614.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Antepartum fetal heart rate testing. VII. The significance of fetal bradycardia. Am J Obstet Gynecol. 1981 Jan 15; 139(2):194-8. Druzin ML, Gratacós J, Keegan KA, Paul RH. PMID: 7457534.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Bacteremia in post-Cesarean section endomyometritis: differential response to therapy. Obstet Gynecol. 1980 May; 55(5):587-90. DiZerega GS, Yonekura ML, Keegan K, Roy S, Nakamura R, Ledger W. PMID: 7366916.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    64. Diagnosis of fetal death in utero by real-time ultrasound. Obstet Gynecol. 1980 Feb; 55(2):191-3. Platt LD, Manning FA, Murata Y, Keegan KA, Druzin ML, Socol ML. PMID: 7352079.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Antepartum fetal heart rate testing. IV. The nonstress test as a primary approach. Am J Obstet Gynecol. 1980 Jan 01; 136(1):75-80. Keegan KA, Paul RH. PMID: 6444346.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Antepartum fetal heart rate testing. V. The nonstress test--an outpatient approach. Am J Obstet Gynecol. 1980 Jan 01; 136(1):81-3. Keegan KA, Paul RH, Broussard PM, McCart D, Smith MA. PMID: 7352491.
      View in: PubMed   Mentions: 1     Fields:    
    67. Intrauterine transfusion utilizing linear-array, real-time B scan: a preliminary report. Am J Obstet Gynecol. 1979 Dec 15; 135(8):1115-6. Platt LD, Keegan KA, Druzin ML, Gauthier RJ, Evertson LR, Manning FA. PMID: 117712.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Fetal breathing movements and the nonstress test in high-risk pregnancies. Am J Obstet Gynecol. 1979 Oct 15; 135(4):511-5. Manning FA, Platt LD, Sipos L, Keegan KA. PMID: 484650.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Nonstress antepartum fetal monitoring. Clin Obstet Gynaecol. 1979 Aug; 6(2):351-8. Paul RH, Keegan KA. PMID: 498685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Antepartum fetal heart testing. III. The effect of phenobarbital on the nonstress test. Am J Obstet Gynecol. 1979 Mar 01; 133(5):579-80. Keegan KA, Paul RH, Broussard PM, McCart D, Smith MA. PMID: 443294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Kirk's Networks
    Concepts (314)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California